Open AccessClinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018)
Author(s) -
Yuankai Shi,
Haizhu Chen,
Yan Qin,
Jianliang Yang,
Peng Liu,
Xiaohui He,
Shengyu Zhou,
Liqiang Zhou,
Changgong Zhang,
Yong-Wen Song,
Yueping Liu,
Lin Gui,
Shulian Wang,
Jing Jin,
Hui Fang,
Shu-Nan Qi,
Ning Li,
Yu Tang,
Xin Wang,
Sheng Yang
Publication year - 2022
Publication title -
cancer pathogenesis and therapy
Language(s) - English
Resource type - Journals
ISSN - 2949-7132
DOI - 10.1016/j.cpt.2022.09.006
Subject(s) - medicine , rituximab , diffuse large b cell lymphoma , hazard ratio , vincristine , proportional hazards model , prednisone , oncology , chop , regimen , confidence interval , international prognostic index , lymphoma , cyclophosphamide , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom